PMID: 9444452Jan 28, 1998Paper

Variations in compliance among hypertensive patients by drug class: implications for health care costs

Clinical Therapeutics
J A Rizzo, W R Simons

Abstract

Health care decision-makers require more information on differences in compliance rates associated with alternative classes of antihypertensive drugs and the implications of these differences for health care utilization and costs. We examined medical claims data from the Pennsylvania Medicaid Management Information System to investigate compliance rates for four major antihypertensive drug classes (angiotensin-converting enzyme [ACE] inhibitors, beta-blockers, calcium antagonists, and diuretics) and the health care costs associated with noncompliance. Multivariate analysis was used to relate antihypertensive drug class with compliance and variations in compliance with health care costs. The highest estimated rates of compliance were associated with ACE inhibitors and calcium antagonists, and these rates were significantly greater than with beta-blockers and diuretics. Moreover, poor compliance was associated with higher health care costs. Efforts to increase compliance with antihypertensive drug therapy are needed to improve patient outcomes and reduce health care costs.

References

Sep 1, 1992·European Journal of Epidemiology·S Ruiz de la Fuente TiradoC Cortes Vizcaino
Jan 1, 1992·The British Journal of Psychiatry : the Journal of Mental Science·E D Myers, A Branthwaite
Sep 1, 1990·Archives of Internal Medicine·S A EisenT R Przybeck
Dec 1, 1989·Medical Care·R F MarondeS R Sullivan
Dec 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·D A SclarM A Gill

❮ Previous
Next ❯

Citations

May 26, 2006·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J R CurtisK G Saag
Mar 3, 2007·Pharmacy World & Science : PWS·Ahmet AkiciSule Oktay
Dec 6, 2001·Current Hypertension Reports·R Düsing
Nov 7, 2002·Current Hypertension Reports·William C Gerth
Jul 16, 2002·Current Hypertension Reports·William J Elliott
Sep 12, 2000·Current Hypertension Reports·W B Stason
Sep 12, 2000·Current Hypertension Reports·F B Garfield, J J Caro
Aug 13, 2010·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Marie Krousel-WoodEdward D Frohlich
Jan 30, 2010·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Martin C S WongSian M Griffiths
Jun 10, 2010·Journal of Hypertension·Chete M Eze-NliamRoy C Ziegelstein
Jan 18, 2008·International Journal of Clinical Practice·N MuszbekZ M Khan
May 24, 2011·Advances in Urology·Esequiel RodriguezHillary L Copp
Oct 11, 2008·BMC Medical Informatics and Decision Making·Kristen ReidelAllen Huang
Sep 13, 2012·Patient Preference and Adherence·Azuana RamliThomas Paraidathathu
Mar 25, 2008·Therapeutics and Clinical Risk Management·Nicola Fitz-SimonJohn Feely
Oct 23, 2002·Drugs & Aging·Michele A TedescoFrancesco Natale
Sep 15, 2004·PharmacoEconomics·Luca Degli Esposti, Giorgia Valpiani
Apr 9, 2014·Clinical Interventions in Aging·Edelgard Anna KaiserHans Hendrik Schäfer
Jun 8, 2001·Clinical Therapeutics·J P GrégoireM Gaudet
May 12, 2009·Current Medical Research and Opinion·Bijan J BorahDenise Globe
Feb 10, 2010·Current Medical Research and Opinion·J SignorovitchK H Kahler
Jun 18, 2004·The American Journal of the Medical Sciences·G John ChenCarlos M Ferrario
May 31, 2007·The Canadian Journal of Cardiology·C Ineke Neutel, Norm R C Campbell
Mar 29, 2006·The Canadian Journal of Cardiology·J GrégoireAlain Milot
Jul 14, 2006·Mayo Clinic Proceedings·Chaitanya A SarawateAlan W Bakst
Jan 9, 2007·The American Journal of Medicine·David SiegelJoy Meier
Jan 18, 2006·The Journal of Clinical Hypertension·Elizabeth O Ofili
Aug 19, 2010·British Journal of Clinical Pharmacology·Atholl JohnstonGeorge S Stergiou
Oct 27, 2004·The American Journal of Medicine·Reema Mody, Lesley-Ann Miller
Apr 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·Krista A Payne, J Jaime Caro
Jun 1, 2004·Expert Review of Pharmacoeconomics & Outcomes Research·Stefania LopatrielloPierfrancesco Ruffo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.